Management of Recurrent Hepatocellular Carcinoma

Summary

The management of recurrent hepatocellular carcinoma (HCC) demands a tailored, multidisciplinary approach that balances tumour burden, hepatic reserve and patient fitness. Curative options include repeat hepatectomy in selected patients with sufficient remnant liver function, salvage liver transplantation where organ availability and eligibility criteria permit, and loco-regional ablation such as radiofrequency ablation or microwave ablation for small, accessible lesions. Advances in systemic therapy—encompassing tyrosine kinase inhibitors and immune checkpoint inhibitors—have expanded treatment algorithms for those with multifocal or extrahepatic disease. Optimal outcomes hinge on vigilant surveillance, accurate restaging and personalised decision-making within a specialist hepatobiliary network.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Management of Recurrent Hepatocellular Carcinoma publication trend

The graph below shows the total number of articles in management of recurrent hepatocellular carcinoma across all publications each year (not limited to Nature Index journals).

Technical terms

Hepatectomy: Surgical resection of part of the liver, either primary or repeat, to remove malignant tissue.

Radiofrequency ablation (RFA): Minimally invasive procedure using thermal energy to induce coagulative necrosis of tumour cells.

Salvage liver transplantation: Transplantation performed after initial curative treatment when HCC recurs, subject to selection criteria.

Overall survival: Interval from treatment until death from any cause, reflecting treatment efficacy.

Disease-free survival: Duration from treatment to the detection of tumour recurrence, indicating remission durability.

Milan criteria: Established guidelines for transplant eligibility, limiting tumour number and size to optimise outcomes.

References

  1. Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence. Cancers (2023).
  2. Liver resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis. International Journal of Hyperthermia (2021).
  3. The role of re-resection in recurrent hepatocellular carcinoma. Langenbeck's Archives of Surgery (2022).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.